We are live on
!
Find out more
SCM
Stevens Capital Management Portfolio holdings
AUM
$417M
1-Year Est. Return
54.95%
This Fund
S&P 500
This Quarter
Est. Return
-4.14%
1 Year Est. Return
+54.95%
3 Year Est. Return
+108.43%
5 Year Est. Return
+127.3%
10 Year Est. Return
+330.23%
AUM
$2.78B
AUM Growth
-$32.3M
(-1.2%)
Cap. Flow
+$103M
Cap. Flow
% of AUM
3.71%
Top 10 Holdings %
Top 10 Hldgs %
12.19%
Holding
1,429
New
471
Increased
293
Reduced
210
Closed
447
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$45.7M |
| 2 |
Amgen
AMGN
|
+$38.7M |
| 3 |
Pfizer
PFE
|
+$34.2M |
| 4 |
PARA
Paramount Global Class B
PARA
|
+$32.8M |
| 5 |
Chevron
CVX
|
+$32.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$41.7M |
| 2 |
CELG
Celgene Corp
CELG
|
+$41.3M |
| 3 |
Micron Technology
MU
|
+$35M |
| 4 |
General Dynamics
GD
|
+$34.3M |
| 5 |
Altria Group
MO
|
+$27.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.69% |
| 2 | Healthcare | 14.39% |
| 3 | Industrials | 11.92% |
| 4 | Consumer Discretionary | 10.5% |
| 5 | Technology | 10.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Amgen
AMGN
$213B
| $44.1M | 1.59% |
286,965
+241,558
| +532% | +$38.7M |
|
|
2
Verizon
VZ
$209B
| $43.6M | 1.57% |
+934,377
| New | +$45.7M |
|
3
RTX Corp
RTX
$268B
| $34.9M | 1.26% |
500,486
+246,495
| +97% | +$18.1M |
|
|
4
Pfizer
PFE
$158B
| $33.4M | 1.2% |
+1,050,572
| New | +$34.2M |
|
5
Boeing
BA
$167B
| $31.1M | 1.12% |
224,492
+149,314
| +199% | +$21.8M |
|
6
PNC Financial Services
PNC
$96.9B
| $31M | 1.12% |
324,401
+195,256
| +151% | +$18.5M |
|
7
Medtronic
MDT
$118B
| $30.4M | 1.1% |
410,846
+403,467
| +5,468% | +$30.8M |
|
|
PARA
8
DELISTED
Paramount Global Class B
PARA
| $30.2M | 1.09% |
+543,735
| New | +$32.8M |
|
|
9
Chevron
CVX
$412B
| $30M | 1.08% |
+311,272
| New | +$32.7M |
|
10
Travelers Companies
TRV
$76.3B
| $29.7M | 1.07% |
307,309
+268,185
| +685% | +$27.5M |
|
11
Simon Property Group
SPG
$68.6B
| $29.1M | 1.05% |
168,465
+158,262
| +1,551% | +$29.1M |
|
12
UnitedHealth
UNH
$360B
| $28.9M | 1.04% |
236,606
-128,438
| -35% | -$15.2M |
|
13
McKesson
MCK
$104B
| $28.5M | 1.03% |
126,713
+116,083
| +1,092% | +$26.8M |
|
14
Air Products & Chemicals
APD
$66.3B
| $27.2M | 0.98% |
+214,618
| New | +$29.3M |
|
15
Elevance Health
ELV
$87.2B
| $23.8M | 0.86% |
144,981
+128,725
| +792% | +$20.6M |
|
16
Cardinal Health
CAH
$55.9B
| $23.8M | 0.86% |
284,467
+256,977
| +935% | +$22.7M |
|
17
Blackrock
BLK
$170B
| $22.9M | 0.82% |
66,210
+63,666
| +2,503% | +$23.2M |
|
18
Automatic Data Processing
ADP
$106B
| $22.8M | 0.82% |
284,534
+65,431
| +30% | +$5.58M |
|
19
Intuit
INTU
$87.2B
| $22.5M | 0.81% |
+223,277
| New | +$22.8M |
|
20
Berkshire Hathaway Class B
BRK.B
$1.08T
| $21M | 0.76% |
154,455
+69,672
| +82% | +$9.94M |
|
21
Cencora
COR
$62B
| $20.5M | 0.74% |
+192,730
| New | +$21.7M |
|
22
Coca-Cola
KO
$380B
| $20.1M | 0.73% |
513,564
+189,678
| +59% | +$7.71M |
|
23
Visa
V
$689B
| $19.9M | 0.72% |
296,089
-69,771
| -19% | -$4.73M |
|
24
Lowe's Companies
LOW
$113B
| $19.7M | 0.71% |
+294,609
| New | +$21M |
|
25
Kinder Morgan
KMI
$71.3B
| $19.7M | 0.71% |
513,099
+207,705
| +68% | +$8.67M |
|
Similar funds
AP
MWM
RWM
RSS
EWM
SCM
CWA
AC
Stevens Capital Management's Q2 2015 Portfolio in Review
As of Q2 2015, Stevens Capital Management held 1,429 positions worth $2.78B, down 1.2% from $2.81B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Stevens Capital Management deployed $103M of net new capital in Q2 2015, opening 471 new positions and adding to 293 existing holdings. Its largest new stake was Verizon: 934,377 shares worth $43.6M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 16% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Altria Group, an estimated $27.8M trimmed.
- Stevens Capital Management's largest Q2 2015 buy was Verizon: 934,377 shares worth $43.6M.
- Stevens Capital Management added most to Amgen in Q2 2015, an estimated $38.7M increase.
- Stevens Capital Management's biggest Q2 2015 reduction was Altria Group, cutting an estimated $27.8M.
- Stevens Capital Management fully exited Procter & Gamble in Q2 2015, selling an estimated $41.7M.
- Stevens Capital Management's ten largest holdings make up 12% of its $2.78B portfolio in Q2 2015.
- Stevens Capital Management opened 471 new positions and closed 447 in Q2 2015.
- Stevens Capital Management's portfolio value fell 1.2% quarter-over-quarter to $2.78B.
Based on Stevens Capital Management's 13F filing for Q2 2015, filed 11 Aug 2015.